Table 1.
Ligand | GABABR1a
|
GABABR1b
|
||
---|---|---|---|---|
IC50, μM | Hill coeff. nH | IC50, μM | Hill coeff. nH | |
Agonists | ||||
GABA | 30.5 ± 3.4 | 0.82 ± 0.02 | 30.9 ± 2.9 | 1.03 ± 0.08 |
APPA | 2.5 ± 0.6 | 0.82 ± 0.07 | 2.5 ± 0.4 | 0.87 ± 0.02 |
Baclofen | 31.8 ± 2.3 | 0.85 ± 0.06 | 30.1 ± 4.0 | 0.89 ± 0.14 |
CGP47656 | 14.8 ± 0.9 | 0.73 ± 0.03 | 13.9 ± 1.4 | 0.69 ± 0.12 |
Antagonists | ||||
CGP56999A | 0.0007 ± 0.0001 | 1.33 ± 0.12 | 0.0006 ± 0.0002 | 1.30 ± 0.27 |
CGP62349 | 0.0011 ± 0.0002 | 0.85 ± 0.09 | 0.0007 ± 0.0001 | 0.80 ± 0.13 |
CGP64213 | 0.0023 ± 0.0003 | 1.00 ± 0.09 | 0.0019 ± 0.0004 | 0.97 ± 0.06 |
CGP54626A | 0.0019 ± 0.0004 | 1.06 ± 0.06 | 0.0014 ± 0.0004 | 0.96 ± 0.13 |
CGP71872 | 0.0030 ± 0.0003 | 1.00 ± 0.12 | 0.0026 ± 0.0006 | 0.93 ± 0.07 |
CGP35348 | 20.1 ± 2.5 | 0.82 ± 0.09 | 15.8 ± 3.3 | 0.72 ± 0.03 |
2-OH-saclofen | 67.9 ± 4.4 | 0.90 ± 0.11 | 49.1 ± 11.2 | 0.76 ± 0.04 |
Saclofen | 310 ± 57 | 0.69 ± 0.16 | 299 ± 59 | 0.53 ± 0.02 |
SCH50911 | 0.35 ± 0.02 | 0.86 ± 0.15 | 0.35 ± 0.05 | 0.93 ± 0.04 |
Inhibition of [125I]CGP64213 binding to recombinant human GABABRs by GABAB agonists and antagonists. Membranes from transiently transfected COS-1 cells (hR1a) and stably transfected CHO-K1 (hR1b) were used. IC50 values and Hill coefficients were fitted by using nonlinear regression (prism 2.0, Graph Pad Software, Sand Diego). Values are means ± SEM of three independent experiments. APPA, 3-aminopropylphosphinic acid.